TUCSON, Ariz., March 24, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Christopher Lunt as its Chief Data and Technology Officer. Lunt is a technology executive with more than 25 years of experience building large-scale data and analytics platforms across the federal government, Silicon Valley, and the healthcare sector. Continue reading
Cinova Medical is a medical & life sciences manufacturing company based in Phoenix, Arizona. The team at Cinova is focused on supporting medical device companies through advanced manufacturing solutions while driving innovation in both materials and digital health.Continue reading
Company Served as Sponsor and Provided Operational Leadership for Study Conducted in Partnership with TGen and Virta HealthContinue reading
New program will develop, validate and standardize research tools to develop more sophisticated and relevant models of disease. Continue reading
PHOENIX, AZ (March 17, 2026) — As states across the country compete aggressively for talent, investment, and jobs, the Arizona Chamber Foundation and Arizona Commerce Authority today unveiled ArizonaW1NS a comprehensive competitiveness playbook designed to help Arizona sustain economic growth, strengthen its advantages, and expand opportunity statewide over the next decade.
Arizona’s geographic diversity presents unique healthcare challenges. From tribal lands in the north to rural communities and small towns far from major health systems, many residents face barriers to accessing consistent care. For older adults managing chronic conditions, veterans living far from VA facilities, and patients in underserved regions, distance and connectivity can make routine healthcare difficult.Continue reading
Segment showcases SynCardia Total Artificial Heart supporting patients with advanced heart failure and next-generation development programsContinue reading
TUCSON, Ariz., March 10, 2026– Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of Neurology that offers critical longitudinal insights into how symptoms and functional impacts evolve for individuals with early Parkinson’s disease (PD).Continue reading